Skip to content

Staphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Development

Staphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Development

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02812446
Enrollment
88
Registered
2016-06-24
Start date
2012-02-01
Completion date
2013-12-01
Last updated
2026-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Staphylococcal Infection

Keywords

biofilm, staphylokinase, Staphylococcus aureus, microarrays, bone binding sialoprotein, bone and joint infection, blood group

Brief summary

The purpose of this study is to identify bacterial and/or clinical features involved in the pathogenesis of Staphylococcus aureus implant-associated infections (IAI). Materials & methods: In total, 57 IAI S. aureus and 31 nasal carriage (NC) S. aureus isolates were studied. Staphylococcus aureus genetic background was obtained by microarray analysis. Multilocus sequence typing was performed to determine clonal complexes (CC). Biofilm production was investigated by resazurin and crystal violet methods

Interventions

OTHERIAI infection
OTHERStaphylococcus aureus nasal carriage infection

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* infected patients with S. Aureus IAI infection * noninfected patients screened for S. aureus nasal colonization at the orthopedic consultation ward

Exclusion criteria

* minor

Design outcomes

Primary

MeasureTime frameDescription
biofilm production measurement in the two groupsseptember 2012The primary aim of this study is to identify phenotypic (biofilm production) markers in two different groups of S. aureus strains isolated from patients with IAI or screened from nasal carrier in noninfected patients undergoing orthopedic surgery. By using resazurin method, IAI and NC nasal carriage isolates were divided into three groups. Isolates were classified as strong, moderate and weak biofilm producers.
Clonal complexes distributionseptember 2012The primary aim of this study is to identify genotypic markers in two different groups of S. aureus strains isolated from patients with IAI or screened from nasal carrier in noninfected patients undergoing orthopedic surgery. IAI and NC isolates genetic background was determined in order to compare the prevalence of individual virulence factor genes. All genes provided by the Alere StaphyType DNA microarray were studied.
IAI and NC nasal carriage isolates genetic backgroundseptember 2012IAI and NC isolates genetic background was determined in order to compare the prevalence of individual virulence factor genes. All genes provided by the Alere StaphyType DNA microarray were studied

Secondary

MeasureTime frameDescription
biofilm production correlation with genotypedecember 2013quantile-quantile (QQ)-plot analysis
Correlation between Clonal Complexes distribution , genotype and clinical parametersdecember 2013In order to determine whether clusters of S. aureus could be associated with clinical characteristics of the patients, search of association between CCs and clinical data was performed
Association of ABO group phenotype and IAI S. aureus genotypedecember 2013QQ-plots analysis

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 25, 2026